Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Works matching IS 11707690 AND DT 2004 AND VI 22 AND IP 7
Results: 7
1
2
Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?
- Published in:
- 2004
- By:
- Publication type:
- journal article
3
Economic Evaluations of Treatments for Systemic Fungal Infections: A Systematic Review of the Literature.
- Published in:
- PharmacoEconomics, 2004, v. 22, n. 7, p. 421, doi. 10.2165/00019053-200422070-00002
- By:
- Publication type:
- Article
4
Management and costs of treating lung cancer patients in a university hospital.
- Published in:
- 2004
- By:
- Publication type:
- journal article
5
Drotrecogin alfa (activated): a pharmacoeconomic review of its use in severe sepsis.
- Published in:
- 2004
- By:
- Publication type:
- journal article
6
Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C.
- Published in:
- PharmacoEconomics, 2004, v. 22, n. 7, p. 477, doi. 10.2165/00019053-200422070-00005
- By:
- Publication type:
- Article
7
Cost Effectiveness of Peginterferon α-2a Plus Ribavirin versus Interferon α-2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors' Reply.
- Published in:
- 2004
- By:
- Publication type:
- Letter